Epitalon vs KGLOW: What Is the Difference?
Four amino acids against a mixture of several peptides — and a fiftyfold difference in what arrives in the vial.
In plain English
Epitalon is a four-amino-acid molecule from Soviet pineal gland research, studied in ageing and cellular research and supplied in small vials.
KGLOW (or KLOW) holds four compounds in 80 mg: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg.
The difference, without the jargon
Beyond belonging to different research areas, these two illustrate opposite ends of laboratory simplicity. Epitalon is about as straightforward as chemistry gets here: four amino acids, no light sensitivity, instant dissolution, one number on the lab report. KGLOW is a mixture at a high fill mass, which means two things to plan for. First, the arithmetic — 80 mg needs proportionally more liquid, and using a habitual volume produces something far more concentrated than intended. Second, verification — a mixture needs each ingredient identified with a stated ratio, since overall purity says nothing about the balance between components. Neither is better; they answer different questions and demand different care.
Common questions
What is the difference between Epitalon and KGLOW?
Epitalon is a single four-amino-acid molecule studied in ageing research. KGLOW is an 80 mg blend of GHK-Cu, BPC-157, TB-500 and KPV, studied in skin research.
How much liquid should a high-fill vial get?
Enough to reach the concentration you actually want, which means doing the arithmetic rather than reaching for a habitual volume. An 80 mg vial and a 10 mg vial given the same liquid differ eightfold in concentration.
Does a smaller molecule mean a simpler lab report?
Usually yes. A single small molecule needs its weight and purity confirmed. A blend needs each ingredient identified separately with a ratio, which is a more involved analysis and a more informative document when done properly.
Technical reference below
How they actually differ
Comparing the two: Epitalon is synthetic tetrapeptide (ala-glu-asp-gly), while KGLOW is four-component dermal research blend — ghk-cu 50 mg / bpc-157 10 mg / tb-500 10 mg / kpv 10 mg (80 mg total) — different molecular classes with different handling consequences; they call for different primary diluents (sterile or bacteriostatic water versus bacteriostatic water (0.9% benzyl alcohol)); their leading degradation routes differ (aspartate-glycine isomerisation for Epitalon, copper dissociation from the ghk-cu component at acidic ph or on chelator contact for KGLOW), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
Epitalon — origin
Epitalon is a four-residue peptide derived by Vladimir Khavinson's group from Epithalamin, a pineal gland extract studied in the Soviet Union from the 1970s. It represents the reductionist end of the peptide field — the attempt to identify the shortest sequence retaining the activity of a complex tissue extract. At 390 Da it is the smallest compound in this catalogue by a wide margin.
KGLOW — origin
KGLOW is GLOW with a fourth component added: KPV, a tripeptide (Lys-Pro-Val) corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone. The other three amounts are unchanged — GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg — with KPV at 10 mg bringing the vial to 80 mg. KPV is studied primarily for anti-inflammatory activity in preclinical models, notably retaining that property of the parent hormone without its pigmentation-related effects.
Epitalon research themes
The most-cited claim in the Epitalon literature, examined in cell-culture models.
Follows from its Epithalamin origin; studied for effects on circadian signalling in animal models.
A long-running Russian research programme examined lifespan endpoints in rodent models.
Epitalon is the flagship of Khavinson's "peptide bioregulator" framework, a distinct research tradition worth understanding as context.
KGLOW research themes
The majority component, with the deepest dermal research literature.
The addition that distinguishes KGLOW — studied for anti-inflammatory activity derived from alpha-MSH without pigmentation effects.
Two complementary tissue-repair mechanisms, unchanged from GLOW.
Adds an inflammation arm to the three repair-focused mechanisms in GLOW.
Epitalon handling
- Do not over-engineer storage for this compound — refrigeration and a sound seal are genuinely sufficient.
- Avoid prolonged storage of reconstituted solution, since Asp-Gly isomerisation is slow but cumulative.
- Verify the analytical method behind any purity figure, as short polar peptides are easy to under-resolve.
KGLOW handling
- Never reconstitute in acidic diluent — copper dissociation from the GHK-Cu component is the primary risk.
- Keep EDTA and other chelators out of any buffer used with KGLOW.
- Treat colour as data: clear even blue is correct; pale or green is not.
- Protect from light and minimise headspace exposure for the TB-500 component.
- Scale diluent to the 80 mg fill — habitually adding 2 mL as though to a 10 mg vial gives a solution eight times more concentrated than intended.
Both third-party tested
Every Popular Peptides batch of Epitalon and KGLOW is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
Epitalon reference
Related comparisons
Epitalon and KGLOW are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.